In this second article of a planned series about bacterial endotoxin testing, the author shares best practices about prerequisites and reagent preparation for a gel clot Limulus amebocyte lysate (LAL) test.
- Trans-Arterial Micro-Perfusion For Improved Drug Delivery
- Long Live Design Controls, Part II: A Systems Engineering Perspective In The QMSR Paradigm
- The Key to Regulatory Innovation? Global Harmonization
- Balancing Sustainability With Patient Safety In Medical Device Design
- EMA Updates Guidance On Inhalation And Nasal Product Quality
- Quick Read: FDA's New Draft Guidance On Data Integrity For In Vivo BA/BE Studies
- A Holistic Approach To Container Closure Integrity
- New FDA Draft Guidance: Data Integrity For In Vivo Bioavailability And Bioequivalence Studies
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Packaging/Delivery System Integrity And Self-Sealing Capacity Of Vial Systems
Review the scope and testing procedures required by General Chapter USP <382> Elastomeric Component Functional Suitability in Parenteral Product Packaging/Delivery Systems.
-
Solutions For Challenging Compounds Using Softgel Innovation
The significant interest in semi-solid systems for the potential of extended release profiles has prompted researchers to develop alternative encapsulating systems.
-
Plan For Your Extractables And Leachables Studies To Meet Submission Timelines
Demonstrating the compatibility of any material in contact with drug product throughout its lifecycle (manufacture, containment, and delivery) is a necessity for a regulatory submission.
-
How Recent Trends Impact Bringing Your Molecule To Market
With accelerated approval times, growing competition between drugs, and a shift from hospital to home care, you’re under pressure to develop a delivery device in parallel with your drug.
-
A Smarter Strategy For Optimizing Oncology Drug Products
John McDermott, VP of Scientific Consulting, shares insights on the benefits of evaluating targeted oncology molecules in healthy volunteers and applying an effective platform to accelerate drug product optimization.
-
Have You Selected The Right Stopper For Your Lyophilized Drug Product?
Component selection is a complex process. Packaging considerations should occur concurrent with drug development to mitigate risk at every step of the drug development process.
-
A Taste Masked And Easily Swallowed Malaria Drug For Elderly Patients
Dysphagia impacts treatment compliance and disproportionately affects the elderly. Learn how microencapsulation enabled formulation of a water-soluble powder drives patient adherence.
-
10 Ways To Align Your Medical Device With Human Factors Industry Best Practices
Discover how patient-centric design principles can improve the development of medical devices. By focusing on user needs and behaviors, manufacturers can ensure that products align with expectations.
-
Overcoming The Challenge Of Maintaining Sterility At Low Temperature Storage
Learn about a biotech company with a recently approved gene therapy product that needed to select a packaging solution to meet their needs for storage at low temperatures and still get to market quickly.
-
Key Considerations For Selecting Fill/Finish Manufacturing Technologies
Obtaining information and proactively mapping out your fill/finish strategy early can de-risk an investment in equipment or processes, ensuring you meet your long-term needs.
Tom ensures that Drug Delivery Leader provides you with indispensable resources for staying current on the industry’s most innovative thinking. Get in touch today!
FRANKLY FRAN
-
Regulations and standards for drug delivery systems and packaging are ever evolving and expanding, making it harder and more costly for older products to meet them. In this article, Fran DeGrazio explains why it is imperative that pharma companies consider new product adoption.